# CSF Metabolomics and Glymphatic Function in Patients Receiving VP- Shunt Surgery.

> **NCT06005363** · NA · RECRUITING · sponsor: **Chang Gung Memorial Hospital** · enrollment: 48 (estimated)

## Conditions studied

- The Association of Postoperative Cognitive Dysfunction With Glymphatic Function and Neuroinflammation
- The Association of Postoperative Cognitive Dysfunction With CSF Metabolomic Change

## Interventions

- **DRUG:** Dexmedetomidine
- **DEVICE:** anesthesia depth monitoring

## Key facts

- **NCT ID:** NCT06005363
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005363, "CSF Metabolomics and Glymphatic Function in Patients Receiving VP- Shunt Surgery.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06005363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*